Back to results
US 2006/0217424 A1Published application
Compounds for the inhibition of nitric oxide synthase
AssigneeAstraZeneca AB
InventorsStephen Connolly, Glen Ernst
Life of this patent
Estimating the term…
Abstract
There are provided novel compounds of formula (I) wherein A, R1, R3, R4, R5, T, U, V, W, X and Y are as defined in the specification, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory diseases, pain and CNS diseases.
Claims14
A compound of formula (I)
- wherein:
- A represents a phenyl ring or A represents a C8 to 10 aromatic or partially aromatic bicyclic ring system;
- R represents C1 to 6 alkyl, C1 to 6 alkoxy, halogen, hydroxy, cyano, trifluoromethyl or NR6R7;
- R3 represents hydrogen, C1 to 6 alkyl, C2 to 6 alkenyl, C3 to 6 cycloalkyl, C1 to 6 alkylthio, C1 to 6 alkoxy, halogen, hydroxy, cyano, trifluoromethyl or NR8R9, said alkoxy group being optionally further substituted by hydroxy or by one or more fluorine atoms;
- or R3 represents phenyl or a five- or six-membered aromatic heterocyclic ring containing 1 to 3 heteroatoms independently selected from O, S and N, said phenyl or aromatic heterocyclic ring being optionally substituted by one or more substituents selected independently from halogen, C1 to 4 alkyl, C1 to 4 alkoxy, hydroxy, cyano or NR8R9, said alkyl or alkoxy group being optionally further substituted by one or more fluorine atoms;
- R4 and R5 independently represent hydrogen or C1 to 6 alkyl, said alkyl group being optionally substituted by OH, C1 to 6 alkoxy, NR10R11 or phenyl, said phenyl group being optionally further substituted by C1 to 6 alkyl, C1 to 6 alkoxy, halogen, hydroxy, cyano or NR12R13;
- R6, R7, R8, R9, R10, R11, R12 and R13 independently represent hydrogen or C1 to 6 alkyl, said alkyl group being optionally substituted by OH or C1 to 6 alkoxy;
- or the groups NR4R5, NR6R7 and NR8R9 independently represent a 4- to 7-membered saturated azacyclic ring optionally incorporating one further heteroatom selected from O or N, said ring being optionally substituted by OH, C1 to 3 hydroxyalkyl or C1 to 3 alkoxy;
- V represents cyano or nitro;
- X represents O or S(O)n;
- n represents an integer 0, 1 or 2;
- Y represents C1 to 6 alkyl;
- any one of T, U and W represents N and the other two independently represent CR2 and each R2 group independently represents hydrogen, C1 to 3 alkyl, C1 to 3 alkoxy or halogen;
- or a pharmaceutically acceptable salt thereof.
11 more elements
Dependencies are inferred from the claim text.